Rigaku Pharmaceutical Technologies Showcase Globe IconRigaku Global Website Email Iconpharma@rigaku.com
Rigaku Pharmaceutical Technologies Showcase Globe IconRigaku Global Website Email Iconpharma@rigaku.com Phone Icon

    XRD Application to Pharmaceuticals

    Webinar Series

    This webinar series explains component analysis and standardless quantitative analysis concepts in the pharmaceutical space.

    Email us at pharma@rigaku.com if you have questions or requests for future mini-tutorial topics. 

     

    Component Analysis and Standardless Quantitative Analysis for Pharmaceutical Applications

    June 27, 2023

    Traditional quantitative analysis of solid-form content in a solid sample is challenging. Most notably in the production of representative standard calibration samples covering the concentration range of interest. In addition to weighing, mixing, and homogeneity errors, the resulting boutique standards will likely be not representative of the unknown material being analyzed.

    The ideal solution has always been a Standardless Quantitative approach that is representative and relevant to the materials being studied. Component analysis using equal area scaling can make this ideal quantitative analysis solution a reality. 

     

    Watch The Recording

    Simultaneous XRD-DSC – the sum is much greater than the parts

    August 22, 2023

    Almost all analytical labs supporting the Pharmaceutical industry will have both Thermal analysis tools and X-ray powder diffraction. So, what is the benefit of combining simultaneous DSC and XRD measurements into a single attachment. It turns out that having the simultaneous thermal and powder data on the same sample yields a wealth of information that is often not easily accessible using each analytical technique separately.

    Watch The Recording

    Total Diffraction and Amorphous Material Characterization

    October 31, 2023

    X-ray powder diffraction is regarded as the gold standard with respect to the characterization of crystalline solid forms in pharmaceutical materials. However, the traditional Bragg peak crystalline methods become less relevant with the general trends of the increasing complexity of active molecules and the prevalence of non-crystalline forms (amorphous, meso-phasic, nano-phases, etc.).

     

    Watch The Recording

    Simon-Bates-New-2022

    Simon Bates | VP of Science and Technology

    Rigaku Americas Corporation  |  Texas, USA

    simon.bates@rigaku.com  |  +1-281-362-2300

    Simon Bates is V.P. of Science and Technology at Rigaku Americas Corp., where he nurtures collaborative relationships between industry partners and academia in the discovery of new technologies and methodologies for the next generation analytical systems. His fascination with materials science and analytics has led Dr. Bates on an interesting career path. Having received his Ph.D. from the University of Hull for his neutron diffraction studies on the magnetic properties of rare earth materials, Dr. Bates completed his postdoctoral work at the University of Edinburgh where he first started to design and build specialized high resolution X-ray diffraction system for materials characterization. He continued working on X-ray analytical systems and software design throughout his career at Philips, Shimadzu (Kratos), Bede Scientific, and Rigaku. However, before joining Rigaku, Dr. Bates explored a different career direction and spent 17 years working in pharmaceutical contract research at SSCI and then Triclinic Labs., where he expanded his toolkit for materials analysis to embrace thermal methods and IR/Raman spectroscopy while experimenting in organic chemistry and molecular modeling. Dr. Bates has continued his relationship with academia, volunteering as an Adjunct Professor at Purdue University, University of Hawaii Hilo and more recently at the University of Long Island. Want to learn more? Connect with Simon on LinkedIn.